Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction

Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction

Abstract Aims Sacubitril/valsartan combines renin–angiotensin–aldosterone system inhibition with amplification of natriuretic peptides. In addition to well‐described effects, natriuretic peptides exert direct effects on pulmonary vasculature. The effect of sacubitril/valsartan on pulmonary artery pr...

Full description

Bibliographic Details
Main Authors: Jeffrey S. Tran, Ofer Havakuk, Jennifer M. McLeod, Jennifer Hwang, Hoi Yan Kwong, David Shavelle, Michael R. Zile, Uri Elkayam, Michael W. Fong, Luanda P. Grazette
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
Heart failure
Pulmonary hypertension
Remote monitoring
Heart failure reduced ejection fraction
Implantable monitors
Neprilysin
Online Access:https://doi.org/10.1002/ehf2.13225

Internet

https://doi.org/10.1002/ehf2.13225

Similar Items